…
← Tracker

Institutional

TRV GP IV, LLC

CIK 0001688325
$266.9M
Reported AUM
2
Positions
Q1 2026
Period
2026-05-07
Filed

The Brief · TRV GP IV, LLC · Q1 2026

AI · grounded in 13F

TRV GP IV, LLC reduced its position in Tango Therapeutics, Inc. TNGX by 19.05%. The fund added no new positions during the period. Total assets under management stood at $266.9M across two holdings.

Portfolio · Q1 2026

MAZE$133.5MTNGX$133.4MTL

Top holdings

QoQ vs Q4 2025

#StockIssuerPriceDay %1Y Gr.5Y Gr.Value% of bookΔ shares (QoQ)Status
1MAZEMAZE THERAPEUTICS, INC.$24.05-0.17%79.48%96.65%$133.5M50.04%—HELD
2TNGXTANGO THERAPEUTICS, INC.$30.943.76%559.70%208.66%$133.4M49.96%−1,500,000−19.0%

Source: SEC EDGAR · accession 0001193125-26-212011. 13F discloses long positions only — shorts, foreign equities, and options are excluded.